Education
About Us
Working with TipRanks
Follow Us
EVE Health Group Limited (AU:EVE)
:EVE
EVE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.04
Previous CloseN/A
Volume9.81K
Average Volume (3M)978.28K
Market Cap
AU$5.27M
Enterprise ValueN/A
Total Cash (Recent Filing)AU$384.92K
Total Debt (Recent Filing)AU$151.70K
Price to Earnings (P/E)―
Beta-0.03
Next Earnings
Aug 27, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 25, 2010Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding131,862,720
10 Day Avg. Volume978,280
30 Day Avg. Volume978,280
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)15.35
Price to Sales (P/S)0.00
P/FCF Ratio-3.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EVE Health Group Limited News
PremiumCompany Announcements
EVE Health Group Announces Changes in Substantial Shareholders
PremiumCompany Announcements
Stuart Gunzburg Acquires Substantial Holding in EVE Health Group
PremiumCompany Announcements
EVE Health Group Appoints New Director with Significant ShareholdingPremiumCompany Announcements
EVE Health Group Completes Strategic Acquisition of Nextract Pty Ltd
PremiumCompany Announcements
EVE Health Group Announces Quotation of New Securities on ASX
PremiumCompany Announcements
EVE Health Group Limited Announces New Share Offers in Latest Prospectus
PremiumCompany Announcements
EVE Health Group Announces Share Consolidation Impacting Director’s Holdings
PremiumCompany Announcements
EVE Health Group Completes Share ConsolidationEVE FAQ
What was EVE Health Group Limited’s price range in the past 12 months?
EVE Health Group Limited lowest share price was AU$0.02 and its highest was AU$0.04 in the past 12 months.
What is EVE Health Group Limited’s market cap?
EVE Health Group Limited’s market cap is AU$5.27M.
When is EVE Health Group Limited’s upcoming earnings report date?
EVE Health Group Limited’s upcoming earnings report date is Aug 27, 2025 which is in 76 days.
How were EVE Health Group Limited’s earnings last quarter?
EVE Health Group Limited released its earnings results on Feb 28, 2025. The company reported -AU$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.006.
Is EVE Health Group Limited overvalued?
According to Wall Street analysts EVE Health Group Limited’s price is currently Overvalued.
Does EVE Health Group Limited pay dividends?
EVE Health Group Limited pays a Notavailable dividend of AU$0.05 which represents an annual dividend yield of N/A. See more information on EVE Health Group Limited dividends here
What is EVE Health Group Limited’s EPS estimate?
EVE Health Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EVE Health Group Limited have?
EVE Health Group Limited has 131,862,720 shares outstanding.
What happened to EVE Health Group Limited’s price movement after its last earnings report?
EVE Health Group Limited reported an EPS of -AU$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of EVE Health Group Limited?
Currently, no hedge funds are holding shares in AU:EVE
EVE Health Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:EVE Sentiment 70%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-105.17%
Trailing 12-Months
Asset Growth
-75.42%
Trailing 12-Months
Company Description
EVE Health Group Limited
Eve Health Group Limited, together with its subsidiaries, engages in the production and distribution of nutrition, health, and wellness products in Australia, New Zealand, the Asia Pacific, and North America. It provides organic tea tree oils; and distributes botanical oils, as well as supplies essential oils, hydrosols, extracts, carrier oils, and seed oils. The company also offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. In addition, it offers medical nutrition solutions for chronic and lifestyle diseases, including Gluco Smooth for type 2 diabetes that reduces the post-meal blood sugar levels; and dietary interventions. The company was formerly known as EVE Investments Limited. Eve Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.